Blue Owl Capital Holdings
Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PLRX, HOOD, CGEM, TRML, KVYO, and represent 49.50% of Blue Owl Capital Holdings's stock portfolio.
- Added to shares of these 10 stocks: PLRX (+$54M), CGEM (+$35M), TRML (+$32M), RPTX (+$23M), SLRN (+$17M), LRMR (+$16M), KROS (+$14M), RARE (+$13M), ENGN (+$11M), SYRS (+$8.5M).
- Started 30 new stock positions in IMVT, IKNA, ENGN, IRON, Orchard Therapeutics, OMGA, BRZE, MLYS, KROS, SGMT.
- Reduced shares in these 3 stocks: , GTLB, Fathom Digital Mfg Corp.
- Sold out of its positions in GTLB, STWD.
- Blue Owl Capital Holdings was a net buyer of stock by $287M.
- Blue Owl Capital Holdings has $418M in assets under management (AUM), dropping by 223.51%.
- Central Index Key (CIK): 0001858703
Tip: Access up to 7 years of quarterly data
Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Blue Owl Capital Holdings
Blue Owl Capital Holdings holds 43 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pliant Therapeutics (PLRX) | 13.0 | $54M | NEW | 3.0M | 18.11 |
|
| Robinhood Mkts Com Cl A (HOOD) | 12.9 | $54M | 4.2M | 12.74 |
|
|
| Cullinan Oncology (CGEM) | 8.3 | $35M | NEW | 3.4M | 10.19 |
|
| Tourmaline Bio (TRML) | 7.7 | $32M | NEW | 1.3M | 24.31 |
|
| Klaviyo Com Ser A (KVYO) | 7.5 | $32M | 1.2M | 26.25 |
|
|
| Owl Rock Capital Corporation (OBDC) | 7.2 | $30M | 2.0M | 14.76 |
|
|
| Repare Therapeutics Ord (RPTX) | 5.4 | $23M | NEW | 3.1M | 7.30 |
|
| Acelyrin (SLRN) | 4.1 | $17M | NEW | 2.3M | 7.46 |
|
| Larimar Therapeutics (LRMR) | 3.7 | $16M | NEW | 3.4M | 4.55 |
|
| Keros Therapeutics (KROS) | 3.4 | $14M | NEW | 353k | 39.76 |
|
| Ultragenyx Pharmaceutical (RARE) | 3.0 | $13M | NEW | 263k | 47.82 |
|
| Engene Holdings (ENGN) | 2.7 | $11M | NEW | 1.2M | 9.23 |
|
| Syros Pharmaceuticals Com New (SYRS) | 2.0 | $8.5M | NEW | 1.5M | 5.67 |
|
| Disc Medicine (IRON) | 1.9 | $8.1M | NEW | 140k | 57.76 |
|
| E2open Parent Holdings Com Cl A (ETWO) | 1.7 | $7.2M | 1.7M | 4.39 |
|
|
| Blueprint Medicines (BPMC) | 1.6 | $6.6M | NEW | 72k | 92.24 |
|
| Toast Cl A (TOST) | 1.4 | $6.0M | +1725% | 5.9M | 1.03 |
|
| Inozyme Pharma (INZY) | 1.3 | $5.4M | NEW | 1.3M | 4.26 |
|
| Mineralys Therapeutics (MLYS) | 1.2 | $4.9M | NEW | 568k | 8.60 |
|
| Compass Therapeutics (CMPX) | 1.1 | $4.4M | NEW | 2.8M | 1.56 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.9 | $3.9M | NEW | 65k | 60.39 |
|
| Ikena Oncology (IKNA) | 0.9 | $3.8M | NEW | 2.0M | 1.97 |
|
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.8 | $3.3M | NEW | 340k | 9.69 |
|
| Omega Therapeutics Common Stock (OMGA) | 0.8 | $3.2M | NEW | 1.1M | 3.01 |
|
| Ovid Therapeutics (OVID) | 0.7 | $2.8M | NEW | 865k | 3.22 |
|
| Dell Technologies SHS (DELL) | 0.6 | $2.7M | NEW | 35k | 76.50 |
|
| Orchard Therapeutics Spon Ads New | 0.6 | $2.6M | NEW | 1.6M | 1.65 |
|
| Immunovant (IMVT) | 0.6 | $2.5M | NEW | 60k | 42.13 |
|
| Black Diamond Therapeutics (BDTX) | 0.5 | $2.0M | NEW | 695k | 2.81 |
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.5 | $1.9M | NEW | 355k | 5.42 |
|
| Adc Therapeutics Sa SHS (ADCT) | 0.3 | $1.2M | 734k | 1.66 |
|
|
| Gohealth Com Cl A (GOCO) | 0.3 | $1.1M | 83k | 13.34 |
|
|
| Braze SHS (BRZE) | 0.2 | $942k | NEW | 18k | 53.13 |
|
| Blend Labs Cl A (BLND) | 0.2 | $922k | 362k | 2.55 |
|
|
| Rallybio Corp (RLYB) | 0.2 | $837k | NEW | 350k | 2.39 |
|
| Desktop Metal Com Cl A (DM) | 0.1 | $563k | 750k | 0.75 |
|
|
| Freeline Therapeutics Hldgs Sponsored Ads | 0.1 | $552k | NEW | 87k | 6.37 |
|
| Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.1 | $404k | NEW | 475k | 0.85 |
|
| Uber Technologies (UBER) | 0.1 | $381k | 6.2k | 61.57 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.1 | $296k | +109% | 10k | 29.52 |
|
| Fathom Digital Mfg Corp Cl A Com | 0.1 | $223k | -50% | 50k | 4.46 |
|
| Precision Biosciences Ord | 0.1 | $221k | NEW | 607k | 0.36 |
|
| Alpha Partners Tech Mergr *w Exp 03/31/202 (PLMJW) | 0.0 | $0 | 667k | 0.00 |
|
Past Filings by Blue Owl Capital Holdings
SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021
- Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
- Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
- Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
- Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
- Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
- Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022
- Blue Owl Capital Holdings 2022 Q2 filed Aug. 12, 2022
- Blue Owl Capital Holdings 2021 Q4 restated filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 amended filed May 16, 2022
- Blue Owl Capital Holdings 2022 Q1 filed May 16, 2022
- Blue Owl Capital Holdings 2021 Q4 filed Feb. 11, 2022